Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme Semple

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Idrugs : the Investigational Drugs Journal|April 8, 2010
Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual ConferenceGraeme Semple
Current Opinion in Drug Discovery & Development|July 31, 2007
Recent progress in the discovery of niacin receptor agonistsGraeme Semple, P Douglas Boatman, Jeremy G Richman
Journal of Medicinal Chemistry|November 6, 2008
Nicotinic acid receptor agonistsP Douglas Boatman, Jeremy G Richman, Graeme Semple
Current Opinion in Pharmacology|October 16, 2003
Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptorsRobert M Jones, P Douglas Boatman, Graeme Semple, et al.
Pharmacological Reviews|April 2, 2011
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)Stefan Offermanns, Steven L Colletti, Timothy W Lovenberg, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methodsGraeme Semple, Britt Marie Andersson, Vijay Chhajlani, et al.
CNS Drug Reviews|April 15, 2006
ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxietyShigeyuki Chaki, Jun-ichi Yamaguchi, Hisaharu Yamada, et al.
Cellular Signalling|June 22, 2018
Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptorIbragim Gaidarov, John Adams, John Frazer, et al.
Pharmacological Research|February 23, 2018
Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptorIbragim Gaidarov, Todd Anthony, Joel Gatlin, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
3-Aryl pyridone derivatives. Potent and selective kappa opioid receptor agonistsGraeme Semple, Britt-Marie Andersson, Vijay Chhajlani, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Idrugs : the Investigational Drugs Journal|April 8, 2010
Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual ConferenceGraeme Semple
Current Opinion in Drug Discovery & Development|July 31, 2007
Recent progress in the discovery of niacin receptor agonistsGraeme Semple, P Douglas Boatman, Jeremy G Richman
Journal of Medicinal Chemistry|November 6, 2008
Nicotinic acid receptor agonistsP Douglas Boatman, Jeremy G Richman, Graeme Semple
Current Opinion in Pharmacology|October 16, 2003
Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptorsRobert M Jones, P Douglas Boatman, Graeme Semple, et al.
Pharmacological Reviews|April 2, 2011
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)Stefan Offermanns, Steven L Colletti, Timothy W Lovenberg, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
Synthesis and Biological activity of kappa opioid receptor agonists. Part 2: preparation of 3-aryl-2-pyridone analogues generated by solution- and solid-phase parallel synthesis methodsGraeme Semple, Britt Marie Andersson, Vijay Chhajlani, et al.
CNS Drug Reviews|April 15, 2006
ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxietyShigeyuki Chaki, Jun-ichi Yamaguchi, Hisaharu Yamada, et al.
Cellular Signalling|June 22, 2018
Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptorIbragim Gaidarov, John Adams, John Frazer, et al.
Pharmacological Research|February 23, 2018
Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptorIbragim Gaidarov, Todd Anthony, Joel Gatlin, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
3-Aryl pyridone derivatives. Potent and selective kappa opioid receptor agonistsGraeme Semple, Britt-Marie Andersson, Vijay Chhajlani, et al.
Pageof 6